AZD-4360
N/A
Report date: 2026/02/13 20:01:31
Base Information
Drug NameAZD-4360
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAstrazeneca Ab
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesBaxter Oncology GmbhAstrazeneca PlcAstrazeneca Ab +[4]
Inactive CompaniesN/A
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A